Leishmaniasis

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS withdrawal · 2025-04-27
Clinical Trial Update: Treatment of Leishmaniasis With Impavido® (Miltefosine): Pregnancy Registry
A pregnancy registry trial evaluating miltefosine (Impavido) for leishmaniasis has been withdrawn.